Why has the WHO asked governments to delay Covid-19 booster jabs?
While booster shots will likely be needed long-term, the WHO has argued that first jabs for poorer nations should be prioritised.
Supply Chain
AstraZeneca and EU reach settlement over delayed Covid-19 vaccine doses
The agreement puts an end to the legal dispute initiated by the EU against AstraZeneca...
Has Covid-19 exposed the weakness of the US pharma supply chain?
A recent study revealed that over 80% of APIs for essential medicines across key therapeutic...
Human rights considerations imperative for Covid-19 vaccines in developing countries
The distribution of Covid-19 vaccines has revealed the extent to which developed nations and pharma...
Blood plasma production: OK for the UK?
With the UK’s blood plasma donated ban lifted, Abi Millar looks into the risk-benefit analysis...
Rewriting the pharma supply chain for a post-pandemic world
The pandemic has demonstrated the critical need for resilience and agility in pharma supply chains.
Donor compensation could improve Europe’s access to plasma therapies
A report by Copenhagen Economics has highlighted the importance of a long-term plan for blood plasma supply in Europe.
J&J agrees to pay $230m to settle opioid case in New York
The agreement requires J&J to stop the manufacture or sale of opioids in New York and exit the opioid business in the US.
Pfizer and BioNTech to deliver 500 million Covid-19 vaccine doses to the US
The US Government will donate the vaccine doses to low and lower-middle-income countries.
Regenerative medicine: ready for the big leagues?
What is at the cutting-edge of regenerative medicine in 2021, and are these complex products ready to break into the big leagues?
Drug dispensing goes digital
Pharmacists are looking to drive efficiencies in medication management and drug dispensing by leveraging robotic tools.
